Ptc Therapeutics, Inc. (PTCT)
Ptc Therapeutics, Inc. (PTCT) is a Healthcare stock tracked by StreetAlpha. PTCT reports earnings on Tue, Nov 3, 2026. The average 12-month price target from 6 analysts is $109.17, with a high of $137.00 and a low of $85.00. Analyst consensus is Strong Buy, based on the latest ratings from 6 firms (5 buy, 1 hold, 0 sell). Over the past 90 days StreetAlpha recorded 1 whale options trade in PTCT, 100% of them bullish and 0% bearish. In the past 30 days there were 3 dark pool prints totaling $7.0M, the largest $5.3M.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →Based on 6 analysts who set a price target on PTCT in the past 90 days. The average target is $109.17, with a high of $137.00 and a low of $85.00.
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Sep 22 | Cantor Fitzgerald | Target raised | Buy | $130 → $137 |
| Sep 14 | Leerink Partners | Assumed coverage | Buy | $98 |
| Aug 14 | Barclays | Maintained | Buy | $122 |
| Aug 13 | Wells Fargo | Target raised | Buy | $106 → $109 |
| Jul 31 | Morgan Stanley | Maintained | Buy | $104 |
Whale Options Flow
90DDark Pool
30DAI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether PTCT is in one of them and how their past PTCT trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered PTCT in an article yet. Here's the latest on the wider market.
For informational purposes only. Not financial advice. Options flow and dark pool data are delayed and may be incomplete.